Global Lupus Nephritis Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Lupus Nephritis Industry In 2025?

The lupus nephritis market has demonstrated robust expansion over recent years. This market is set to increase from $1.94 billion in 2024 to $2.08 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.4%. The growth observed in the past can be ascribed to greater investments in lupus nephritis research, an increasing prevalence of autoimmune disorders, rising healthcare costs, wider acceptance of biologics, and the growing appeal of telemedicine.

The lupus nephritis market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $2.78 billion by 2029, achieving a compound annual growth rate (CAGR) of 7.5%. This expansion during the forecast period is fueled by factors such as elevated physician awareness, the rising adoption of biologic therapies, an increasing number of specialty clinics, the growing significance of renal transplantation, and improved access to nephrology services. Noteworthy trends in the forecast timeframe encompass advancements in biologic therapies, personalized medicine approaches, novel diagnostic biomarkers, an expansion of clinical trials, and progress in stem cell therapy.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22044&type=smp

Which Factors And Drivers Are Influencing The Lupus Nephritis Market In 2025?

The rising occurrence of genetic predisposition is anticipated to fuel the expansion of the lupus nephritis market in the future. Genetic predisposition describes inherent genetic characteristics in a person that raise their probability of developing specific illnesses or health issues. This growing prevalence of genetic predisposition stems from elements like heredity, environmental factors, and alterations in particular genes. The rising frequency of genetic predisposition is a key contributor to the onset of lupus nephritis, underscoring how inherited genetic factors influence autoimmune conditions, especially those impacting renal function. As an illustration, in October 2024, the Cystic Fibrosis Trust, a UK-based national charity, reported that its UK CF Registry documented 11,148 registered patients in 2022, a figure that grew to 11,318 by 2024, indicating a 1.52% rise in individuals with cystic fibrosis (CF). Consequently, the increasing prevalence of genetic predisposition is propelling the growth of the lupus nephritis market.

What Are The Major Segment Types Covered In The Lupus Nephritis Market?

The lupus nephritismarket covered in this report is segmented –

1) By Stage: Class 1; Class 2; Class 3; Other Stages

2) By Drug Class: Immunosuppressive Drugs; Corticosteroids; Biological Agents; Antimalarial Drugs

3) Route Of Administration: Oral; Parenteral; Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

5) By End-User: Hospitals; Specialty Clinics; Other End-Users

Subsegments:

1) By Class 1: Asymptomatic Cases; Mild Proteinuria; Incidental Diagnosis.

2) By Class 2: Mild Hematuria; Low-Grade Proteinuria; Minimal Immune Complex Deposition.

3) By Class 3: Active Lesions; Chronic Sclerotic Lesions; Crescent Formation.

4) By Other Stages: Class 4 (Diffuse Lupus Nephritis); Class 5 (Membranous Lupus Nephritis); Class 6 (Advanced Sclerotic Lupus Nephritis)

What Trends Are Redefining The Lupus Nephritis Market Dynamics?

Leading companies in the lupus nephritis market are prioritizing the development of advanced second-generation calcineurin inhibitors to boost treatment efficacy and improve long-term kidney outcomes for patients. These second-generation calcineurin inhibitors are utilized in lupus nephritis to mitigate inflammation and prevent kidney damage through the modulation of immune responses. For instance, in September 2024, Aurinia Pharmaceuticals Inc., a Canada-based commercial-stage biopharmaceutical company, disclosed that the Japanese Ministry of Health, Labour, and Welfare granted approval for LUPKYNIS (voclosporin) for the treatment of lupus nephritis. This approval facilitates the use of voclosporin in conjunction with mycophenolate mofetil (MMF), drawing on data from the AURORA Clinical Program, which verified its safety and effectiveness. The approval signifies a major achievement in broadening treatment alternatives for lupus nephritis patients in Japan, thereby enhancing disease management and outcomes.

Which Major Firms Are Strengthening Their Position In The Lupus Nephritis Industry?

Major companies operating in the lupus nephritis market are F. Hoffmann-La Roche Ltd., Bristol Myers Squibb, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Genentech, Astrazeneca PLC, Biocon Biologics, Hanmi Pharmaceutical Co. Ltd., Sana Biotechnology Inc., RemeGen Co. Ltd., Aurinia Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Equillium Inc., Anthera Pharmaceuticals Inc., Atara Biotherapeutics Inc., Artiva Biotherapeutics, Caribou Biosciences, Nkarta Inc., Adicet Bio Inc., Lupus Research Alliance, Kyverna Therapeutics Inc., Kezar Life Sciences, Bionxt Solutions.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/lupus-nephritis-global-market-report

What Regional Growth Trends Are Shaping The Lupus Nephritis Market Outlook?

Asia-Pacific was the largest region in the lupus nephritis market in 2024. The regions covered in the lupus nephritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Lupus Nephritis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=22044&type=smp

Browse Through More Reports Similar to the Global Lupus Nephritis Market 2025, By The Business Research Company

Systemic Lupus Erythematosus Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/systemic-lupus-erythematosus-treatment-global-market-report

Diabetic Kidney Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Kidney Transplant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795